Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: CIPRO

« Back to Dashboard

Summary for Tradename: CIPRO

Suppliers: see list1

Pharmacology for Tradename: CIPRO

Drug ClassQuinolone Antimicrobial

Clinical Trials for: CIPRO

Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis
Status: Completed Condition: Cystic Fibrosis

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis
Status: Completed Condition: Bronchiectasis

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
Status: Completed Condition: Otitis Externa; Otorhinolaryngologic Diseases; Ear Diseases; Otitis

Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
Status: Completed Condition: Otitis Externa; Otorhinolaryngologic Diseases; Ear Diseases; Otitis

Impact of Formulation on Ciprofloxacin Oral Absorption
Status: Completed Condition: Healthy

Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin
Status: Completed Condition: Healthy

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension
Status: Not yet recruiting Condition: Otitis Externa

Ciprofloxacin for Prevention of BK Infection
Status: Recruiting Condition: BK Virus Infection

Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine
Status: Completed Condition: Healthy

Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases
Status: Completed Condition: Respiratory System

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
ciprofloxacin hydrochloride
TABLET;ORAL075747Jun 9, 2004RXNo<disabled><disabled>
Bayer Hlthcare
FOR SUSPENSION;ORAL020780Sep 26, 1997RXYes6,136,347*PED<disabled><disabled>
Baxter Hlthcare
INJECTABLE;INJECTION077888Mar 18, 2008DISCNNo<disabled><disabled>
Watson Labs
ciprofloxacin hydrochloride
TABLET;ORAL076794Jun 9, 2004RXNo<disabled><disabled>
Aurobindo Pharma
ciprofloxacin hydrochloride
TABLET;ORAL077859Apr 26, 2007RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: CIPRO

Drugname Dosage Strength RLD Submissiondate
ciprofloxacinOral Suspension250 mg/5 mL and 500 mg/ 5 mLCipro10/16/2009
« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology